Skip to main content

Anal Fistula

1
Pipeline Programs
4
Companies
7
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

TBF Genie Tissulaire
TBF Genie TissulaireFrance - Mions
1 program
1
SygeLIX-F + SygeLIX-GPhase 11 trial
Active Trials
NCT05638139Completed9Est. Jun 2024
Autonomous Therapeutics
1 program
Liposomal BupivacaineN/A1 trial
Active Trials
NCT07081373Recruiting408Est. Jun 2027
Steel Therapeutics
Steel TherapeuticsIA - Iowa City
1 program
acellular dermal matrix plugN/A1 trial
Active Trials
NCT00951002Unknown1,000Est. Nov 2013
Takeda
TakedaTOKYO, Japan
1 program
ASCsPHASE_34 trials
Active Trials
NCT01663116Completed53Est. Jan 2013
NCT01372969Completed24Est. Sep 2010
NCT01020825Completed148Est. May 2010
+1 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
TakedaASCs
TakedaASCs
TakedaASCs
TBF Genie TissulaireSygeLIX-F + SygeLIX-G
Autonomous TherapeuticsLiposomal Bupivacaine
Steel Therapeuticsacellular dermal matrix plug
TakedaASCs

Clinical Trials (7)

Total enrollment: 1,856 patients across 7 trials

NCT00475410TakedaASCs

Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease

Start: Feb 2007Est. completion: Aug 2009214 patients
Phase 3Completed
NCT01663116TakedaASCs

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

Start: Mar 2011Est. completion: Jan 201353 patients
Phase 1/2Completed
NCT01372969TakedaASCs

Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.

Start: Jun 2009Est. completion: Sep 201024 patients
Phase 1/2Completed
NCT05638139TBF Genie TissulaireSygeLIX-F + SygeLIX-G

Treatment of Ano-perineal Fistulas Resistant to Surgical Treatment with a Gel and Plug of Wharton's Jelly

Start: Jun 2023Est. completion: Jun 20249 patients
Phase 1Completed
NCT07081373Autonomous TherapeuticsLiposomal Bupivacaine

Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients.

Start: Jul 2025Est. completion: Jun 2027408 patients
N/ARecruiting
NCT00951002Steel Therapeuticsacellular dermal matrix plug

The Efficacy of Human Acellular Dermal Matrix in the Treatment of Anal Fistula

Start: Jul 2009Est. completion: Nov 20131,000 patients
N/AUnknown
NCT01020825TakedaASCs

Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled Trial

Start: Sep 2008Est. completion: May 2010148 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,856 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.